Ionis analyst coverage
Web11 apr. 2024 · Finally, StockNews.com assumed coverage on shares of Ionis Pharmaceuticals in a report on Thursday, March 16th. They issued a “hold” rating on the stock. Two analysts have rated the stock with a sell rating, four have given a hold rating and five have issued a buy rating to the stock. Web15 dec. 2024 · Equities researchers at UBS Group started coverage on shares of Ionis Pharmaceuticals (NASDAQ:IONS) in a research report issued to clients and investors on …
Ionis analyst coverage
Did you know?
Web12 apr. 2024 · Sanford C. Bernstein started coverage on shares of Ionis Pharmaceuticals in a research report on Tuesday, March 21st. They set an underperform rating and a $31.00 price target on the stock. WebAnalyst Coverage; Ownership Profile; Financials. SEC Filings; Annual Reports; Governance. Governance Documents; Committee Composition; Investor Resources. …
Web23 sep. 2024 · Analysts at GlobalData have, nevertheless, predicted that Novartis' drug will make $2.5 billion in sales by 2027, ahead of Repatha at $2.2 billion, with Praluent a … WebIONIS PHARMACEUTICALS, INC. : Financial analyst guidance for IONIS PHARMACEUTICALS, INC. Stock Berne Stock Exchange: IONS Berne Stock …
Web2 dagen geleden · Analyst Coverage. The following are some of the brokerage houses and institutions that regularly publish research reports on Infosys Limited. This list should not be considered as complete. Infosys disclaims any obligation to update these references or to include the complete list of brokerage houses and institutions. Web12 apr. 2024 · Ionis Pharmaceuticals (NASDAQ:IONS) Price Target Raised to $42.00 Citigroup Boosts Interactive Brokers Group (NASDAQ:IBKR) Price Target to $95.00 LADENBURG THALM/SH SH Begins Coverage on...
Web11 apr. 2024 · In the last 3 months, 10 analysts have offered 12-month price targets for Ionis Pharmaceuticals. The company has an average price target of $46.1 with a high of …
Web20 mrt. 2024 · Ionis Pharmaceuticals (NASDAQ:IONS) Now Covered by Analysts at StockNews.com Posted by MarketBeat News on Mar 20th, 2024 StockNews.com started … how many siblings did shakespeare haveWebIonis is focused on delivering RNA-targeted therapeutics with transformational potential. Our antisense oligonucleotide drug discovery platform has transformed the lives of patients … how many siblings did stephen king haveWeb20 feb. 2024 · The drug, IONIS-AZ5-2.5RX, or AZD2373, will inhibit an undisclosed target, and AZ will be responsible for development and marketing. Ionis will receive $30 million … how did mar a lago get its nameWebIonis Pharmaceuticals, Inc. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Ionis Pharmaceuticals, Inc.'s performance … how did maratha become a force to reckon withWeb26 jul. 2024 · To learn more about Ionis visit www.ionispharma.com and follow us on twitter @ionispharma. Ionis' Forward-looking Statement. This press release includes forward … how did marbury v. madison affect americaWeb21 mrt. 2024 · Analyst Ratings for Ionis Pharmaceuticals. These 9 analysts have an average price target of $46.56 versus the current price of Ionis Pharmaceuticals at … how many siblings did sybil ludington haveWeb8 mei 2013 · Isis Pharmaceuticals, Inc. 9,000,000 shares of common stock, par value $0.001 per share Underwriting Agreement from IONIS PHARMACEUTICALS INC filed with the Securities and Exchange Commission. how did marbury v madison affect society